Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease

被引:222
|
作者
Vivante, Asaf [1 ,2 ]
Golan, Eliezer [2 ,3 ]
Tzur, Dorit
Leiba, Adi [2 ]
Tirosh, Amir [7 ]
Skorecki, Karl [4 ,5 ]
Calderon-Margalit, Ronit [6 ]
机构
[1] Edmond & Lily Safra Childrens Hosp, Israeli Def Forces Med Corps, Chaim Sheba Med Ctr, Dept Pediat,Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Israel Renal Registry, Bristol, Avon, England
[4] Technion Israel Inst Technol, Rappaport Fac Med, Dept Nephrol, Haifa, Israel
[5] Technion Israel Inst Technol, Res Inst, Haifa, Israel
[6] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth, Jerusalem, Israel
[7] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
关键词
OBESITY-RELATED GLOMERULOPATHY; US CHILDREN; KIDNEY-DISEASE; UNITED-STATES; FOLLOW-UP; PREVALENCE; OVERWEIGHT; POPULATION; PROTEINURIA; ASSOCIATION;
D O I
10.1001/2013.jamainternmed.85
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD. Methods: Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification. Results: During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (>= 95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented. Conclusions: Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.
引用
收藏
页码:1644 / 1650
页数:7
相关论文
共 50 条
  • [21] Serum cholesterol and risk of end-stage renal disease in a cohort of mass screening
    Kunitoshi Iseki
    Yoshiharu Ikemiya
    Koshiro Fukiyama
    Clinical and Experimental Nephrology, 1998, 2 (1) : 18 - 24
  • [22] Coronary Calcifications in End-Stage Renal Disease Patients: A New Link between Osteoprotegerin, Diabetes and Body Mass Index?
    Cianciolo, Giuseppe
    La Manna, Gaetano
    Donati, Gabriele
    Persici, Elisa
    Dormi, Ada
    Cappuccilli, Maria Laura
    Corsini, Serena
    Fattori, Rossella
    Russo, Vincenzo
    Nastasi, Valentina
    Coli, Luigi
    Wratten, Marylou
    Stefoni, Sergio
    BLOOD PURIFICATION, 2010, 29 (01) : 13 - 22
  • [23] The Lived Experiences of Children and Adolescents With End-Stage Renal Disease
    Nicholas, David B.
    Picone, Gail
    Selkirk, Enid K.
    QUALITATIVE HEALTH RESEARCH, 2011, 21 (02) : 162 - 173
  • [24] End-Stage Renal Disease Risk in Different Glomerulonephropathies
    Amechi, Macaulay
    Onuigbo, Chukwukadibia
    MAYO CLINIC PROCEEDINGS, 2018, 93 (07) : 958 - 959
  • [25] Proteinuria and the risk of developing end-stage renal disease
    Iseki, K
    Ikemiya, Y
    Iseki, C
    Takishita, S
    KIDNEY INTERNATIONAL, 2003, 63 (04) : 1468 - 1474
  • [26] END-STAGE RENAL DISEASE A new comorbidity index for estimating mortality risk in ESRD
    Lindholm, Bengt
    Davies, Simon
    NATURE REVIEWS NEPHROLOGY, 2010, 6 (07) : 391 - 393
  • [27] ANALGESICS AND RISK FOR END-STAGE RENAL-DISEASE
    PERNEGER, TV
    WHELTON, PK
    KLAG, MJ
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 138 (08) : 666 - 666
  • [28] Haematocrit and the risk of developing end-stage renal disease
    Iseki, K
    Ikemiya, Y
    Iseki, C
    Takishita, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (05) : 899 - 905
  • [29] Increased body mass index is a risk factor for end- stage renal disease in the Chinese Singapore population
    Lew, Quan-Lan Jasmine
    Jafar, Tazeen Hasan
    Talaei, Mohammad
    Jin, Aizhen
    Chow, Khuan Yew
    Yuan, Jian-Min
    Koh, Woon-Puay
    KIDNEY INTERNATIONAL, 2017, 92 (04) : 979 - 987
  • [30] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514